Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in kidney transplant recipients with diabetes mellitus

被引：0
|
作者：
Buckley, Sophieanne [1 ]
Subramaniam, Yuvanaa [1 ,2 ]
Mallik, Ritwika [1 ,3 ]
Mukuba, Dorcas [1 ]
Casabar, Mahalia [4 ]
Ali, Omer [4 ]
Byrne, Connor [4 ]
Chowdhury, Tahseen A. [1 ]
机构：
[1] Royal London Hosp, Dept Diabet & Metab, 7th Floor,John Harrison House,Whitechapel, London E1 1BB, England
[2] Guys & St Thomas NHS Fdn Trust, Dept Diabet & Metab, London, England
[3] UCL, Ctr Obes Res, London, England
[4] Royal London Hosp, Dept Nephrol, London, England
来源：
DIABETIC MEDICINE | 2024年 / 41卷 / 08期
关键词：
D O I：
10.1111/dme.15383
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Safety and efficacy of sodium-glucose co-transporter-2 inhibitors in patients with kidney transplantation and diabetes mellitus
    Yeggalam, Aparna
    Liebich, Jessica Ann
    Yu, Kevin
    Shrestha, Ekta
    Nadella, Srikanth
    Ahir, Vaishaliben
    Newman, Jennifer
    Lentine, Krista L.
    Caliskan, Yasar
    Abu Al Rub, Fadee
    Dhindsa, Sandeep
    Albert, Stewart G.
    DIABETES OBESITY & METABOLISM, 2023, 25 (06): : 1777 - 1780
  • [2] Safety of sodium-glucose cotransporter 2 inhibitors in kidney transplant recipients with diabetes mellitus
    Cohen, Talia Diker
    Polansky, Amir
    Bergman, Idan
    Ayada, Gida
    Babich, Tanya
    Akirov, Amit
    Steinmetz, Tali
    Dotan, Idit
    DIABETES & METABOLISM, 2025, 51 (03)
  • [3] An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus
    Hsia, Daniel S.
    Grove, Owen
    Cefalu, William T.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2017, 24 (01) : 73 - 79
  • [4] Are Sodium-Glucose Co-Transporter-2 Inhibitors (SGLT2i) Safe to Use in Kidney Transplant Recipients with Diabetes?
    Angjeli, A.
    Montada-Atin, T.
    Nisenbaum, R.
    Dacouris, N.
    Nash, M.
    Zaltzman, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S564 - S564
  • [5] A review of the safety of sodium-glucose co-transporter-2 inhibitors
    O'Hara, Daniel Vincent
    Jardine, Meg J.
    DIABETES OBESITY & METABOLISM, 2025,
  • [6] Single Center Experience With Sodium-Glucose Co-Transporter-2 Inhibitors (SGLT2i) in Kidney Transplant Recipients With Diabetes
    Angjeli, Albi
    Montada-Atin, Tess
    Nisenbaum, Rosane
    Dacouris, Niki
    Nash, Michelle
    Prasad, G.
    Zaltzman, Jeffrey
    CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE, 2024, 11
  • [7] Safety and efficacy of sodium-glucose transporter-2 inhibitors in kidney transplant recipients: preliminary results
    Skalioti, Chrysanthi
    Tsiakas, Stathis
    Smyrli, Maria
    Tsoutsoura, Paraskevi
    Boletis, Ioannis
    Marinaki, Smaragdi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [8] Safety and efficacy of sodium-glucose transporter-2 inhibitors in kidney transplant recipients: preliminary results
    Skalioti, Chrysanthi
    Tsiakas, Stathis
    Smyrli, Maria
    Tsoutsoura, Paraskevi
    Boletis, Ioannis
    Marinaki, Smaragdi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2696 - I2696
  • [9] Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis
    Zaccardi, F.
    Webb, D. R.
    Htike, Z. Z.
    Youssef, D.
    Khunti, K.
    Davies, M. J.
    DIABETES OBESITY & METABOLISM, 2016, 18 (08): : 783 - 794
  • [10] Differentiating sodium-glucose co-transporter-2 inhibitors in development for the treatment of type 2 diabetes mellitus
    Washburn, William N.
    Poucher, Simon M.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (04) : 463 - 486
12345